At a glance
ClinicalIndex Comparison RecordN/ACompleted· 337 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Study to Investigate the Contribution of Basal and Post-prandial Blood Glucose to Overall Glycaemia in Subjects With Normal Glycaemic Metabolism and Type 2 Diabetes
In Brief
An observational study for Diabetes, Type 2. Completed, enrolled 337 participants across 1 site.
Detailed Summary
There was no any China mainland data showing the contribution of BBG and PBG to HbA1c in T2DM patients treated with OADs using the CGM method. Therefore this study is aimed to investigate the contribution of BBG and PBG to HbA1c in Chinese T2DM patients treated with OADs using CGMS. It's expected to generate evidence to support the concept of individualized therapy when patients are uncontrolled by OADs.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes, Type 2
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartNov 2015
First PostedJan 2016
Primary CompletionDec 2019
Study CompletionDec 2019
TodayJul 2026
First PostedJan 7, 2016
Enrollment StartNov 30, 2015
Primary CompletionDec 28, 2019
Study CompletionDec 31, 2019
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 10.5 years ago